Analysis: What is Missing from This Case Presentation

SLIDE 1-8 (Missing / Not Extractable - Likely Image Slides or Structural Slides)

1. Patient Demographics (Missing Details)

• Patient's age, sex, occupation - these are critically relevant in fungal keratitis. Agricultural workers and young males are high-risk groups.
• Socioeconomic status (relevant to compliance and follow-up)
• Address/Rural vs. Urban setting (affects etiology - filamentous fungi more common in rural/agricultural settings)

2. Chief Complaint (Absent or Buried in Image Slides)

• Duration of main complaint (e.g., "pain, redness, and blurred vision left eye for ___ days")
• Mode of onset (sudden vs. gradual)

3. History of Present Illness - Key Elements Missing

• Duration of illness before presentation - How many days/weeks had the ulcer been present?
• Exact nature of trauma - What happened with the grass? Direct corneal injury vs. indirect exposure?
• Prior treatment history in full - FML (fluorometholone) steroid drops are mentioned as a prior exposure, but there is no dedicated slide explaining:
  • Who prescribed the steroids?
  • For how long were steroids used?
  • At what dose/frequency?
  • What was the original indication for FML?
• Prior consultation history - Was the patient seen elsewhere first? This is important because steroid-modified fungal keratitis implies the patient was misdiagnosed (likely as bacterial/viral keratitis) and treated with steroids. This clinical error should be described.
• Timeline of symptom progression - Did vision worsen gradually? Was there initial improvement with steroids before worsening?

4. Ocular History (Incomplete)

• Previous eye surgeries or procedures
• History of contact lens use
• History of previous corneal infections, herpes simplex keratitis (relevant DDx)
• Any pre-existing ocular surface disease (dry eye, blepharitis)
• History of diabetes mellitus affecting the eye
• Use of long-term topical medications

5. Personal/Social History (Incomplete)

• Occupation - critical in this case; agricultural/farming work directly explains filamentous fungal exposure (Fusarium, Aspergillus). This belongs here, not just implied in the diagnosis.
• Immunization history (relevant if atypical organisms considered)
• History of systemic illness - diabetes mellitus, HIV, immunosuppression. These dramatically alter the prognosis and management of fungal keratitis (Candida more likely in immunocompromised patients).

6. Anterior Segment Examination (Major Gap)

7. Posterior Segment Examination (Completely Absent)

• Fundus examination (disc, macula, vessels, periphery)
• This is essential to rule out endophthalmitis, especially since the corneal ulcer is large and deep, and penetration into the anterior chamber (hypopyon) is present
• Vitreous assessment

8. Investigations / Workup (Completely Absent - Major Gap)

• Corneal scraping results - Gram stain, KOH mount, Giemsa stain, Calcofluor white stain
• Culture and sensitivity - which fungal organism was isolated (Fusarium? Aspergillus? Candida?)? What was the sensitivity profile?
• Corneal biopsy - was this done? Important if cultures are negative
• Complete blood count - to assess systemic infection/immunocompromise
• Blood glucose / HbA1c - diabetic patients have worse outcomes with fungal keratitis; almost always checked
• HIV status - atypical fungal keratitis raises immune status concerns
• Slit-lamp photograph documentation - should be included as clinical images with labeled findings
• UBM (Ultrasound Biomicroscopy) or B-scan ultrasound - critical when posterior segment cannot be visualized due to corneal opacity; helps rule out posterior extension/endophthalmitis
• Corneal topography/pachymetry - relevant if PK is being planned

9. Differential Diagnosis (Completely Absent)

10. Initial Management (Slide 28) - Errors and Gaps

• The initial management shows antibacterial treatment (cefazolin, gentamycin), which is appropriate as empirical therapy before cultures. However:
  • Antifungal treatment is absent from slide 28 - Natamycin and fluconazole only appear on slide 30 as if added later, but there is no explanation of the clinical decision-making process that led to switching from antibacterials to antifungals.
  • "Zentamycin" appears to be a misspelling - likely gentamicin. This should be corrected.
  • No explanation is given for why antibacterials were started first - was it because cultures were pending? Was fungal etiology suspected from the start?

• Clinical response monitoring - How was the patient's response assessed? Daily slit-lamp exams?
• When was the diagnosis of fungal keratitis established? (After culture results? After failure of antibacterial treatment?)
• Rationale for adding Timolol - IOP must have been measured and found elevated, but this is not stated
• Rationale for Itraconazole oral - systemic antifungal indication should be stated
• Steroid discontinuation - since prior FML use worsened the infection, explicit documentation of cessation of steroids is important

11. Follow-Up and Outcome (Absent)

• Response to medical treatment - Did the ulcer size change? Did hypopyon resolve?
• Timeline - How many days of medical treatment before PK was decided?
• Visual acuity at discharge - Was it better, same, or worse than PL at admission?
• Criteria used to decide on therapeutic PK - Worsening despite 48-72 hours of antifungal therapy? Perforation risk? Extension to limbus?
• Post-operative plan - What is the expected outcome of PK in this context? High risk of graft failure in active fungal infection should be mentioned.
• Patient counseling - prognosis communication

12. Slide 26 (Empty/Corrupted)

13. Slides 15 and 17-25 (Unreadable / Image-only)

Summary of What Must Be Added

What Was Added / Changed

New Slides Added (★)

Enhanced Slides (✎)

1. Right-click the link → Save link as
2. Try a different browser
3. If you're on mobile, switch to desktop mode

PDF Files

• Cover, Demographics, Chief Complaint, HPI, Past Ocular/Medical History, Drug History, Family & Personal History

• General, Systemic, Visual Acuity, Adnexal, Anterior Segment, Corneal Detail, Fluorescein, Posterior Segment

• Provisional Dx, Differentials, Investigations + Results, Final Diagnosis, Management, Follow-Up, Therapeutic PK, Key Learning Points

Word Document

Corneal Ulcer Diagnostic Flowchart

What the Flowchart Covers

1. Patient entry - red eye + pain + vision loss + white spot
2. Initial assessment - history red flags (steroid use, vegetative exposure, contact lenses)
3. Media clear? - if No → B-scan to rule out endophthalmitis
4. Slit-lamp exam - documents infiltrate character, hypopyon mobility, satellite lesions
5. Infiltrate pattern - branches into Fungal / Bacterial / Herpetic / Acanthamoeba clinical profiles
6. Immediate threat? - perforation/endophthalmitis → emergency escalation
7. Corneal scraping - KOH, Gram, Giemsa, Culture (with sample guide sidebar)
8. Empirical treatment - while awaiting results
9. Culture result - branches into Fungal confirmed / Bacterial confirmed / Negative/no growth with specific drug regimens for each
10. 48-72h review - responding vs. not responding
11. Escalation path - voriconazole, biopsy, intrastromal injection, therapeutic PK
12. Outcome - optical rehabilitation, follow-up